Form 8-K - Current report:
SEC Accession No. 0001437749-24-033650
Filing Date
2024-11-06
Accepted
2024-11-06 16:46:28
Documents
17
Period of Report
2024-11-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nby20241105_8k.htm   iXBRL 8-K 42863
2 EXHIBIT 2.1 ex_743011.htm EX-2.1 586393
3 EXHIBIT 10.1 ex_743012.htm EX-10.1 59706
4 EXHIBIT 99.1 ex_743635.htm EX-99.1 17537
  Complete submission text file 0001437749-24-033650.txt   984158

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA nby-20241105.xsd EX-101.SCH 3401
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20241105_def.xml EX-101.DEF 11804
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20241105_lab.xml EX-101.LAB 15858
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20241105_pre.xml EX-101.PRE 12019
19 EXTRACTED XBRL INSTANCE DOCUMENT nby20241105_8k_htm.xml XML 2950
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33678 | Film No.: 241431788
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)